Predict your next investment

HEALTHCARE | Biotechnology
akesobio.com

See what CB Insights has to offer

Total Raised

$215.55M

Investors Count

16

Deal Terms

1

Akeso Biopharma Funding, Akeso Biopharma Valuation & Akeso Biopharma Revenue

5 Fundings

Akeso Biopharma's latest funding round was a IPO for $331.9M on April 24, 2020.

Akeso Biopharma's latest post-money valuation is from April 2020.

Sign up for a free 30-day trial to see Akeso Biopharma's valuations in April 2020 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/24/2020

IPO

$331.9M

$99M

$0.00B

((9.99x))

FY 1234

1

11/2/2019

Series D

$99M

$0.00B

((9.99x))

FY 1234

10

10/30/2018

Series C

$99M

$0.00B

((9.99x))

FY 1234

10

8/29/2017

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

11/24/2015

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

Date

4/24/2020

11/2/2019

10/30/2018

8/29/2017

11/24/2015

Round

IPO

Series D

Series C

Series B

Series A

Amount

$331.9M

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

10

10

Akeso Biopharma Deal Terms

1 Deal Term

Akeso Biopharma's deal structure is available for 1 funding round, including their IPO from April 24, 2020.

Round

IPO

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

IPO

Akeso Biopharma Investors

16 Investors

Akeso Biopharma has 16 investors. Shenzhen Capital Group invested in Akeso Biopharma's Series D funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/24/2015

11/2/2019

4
Series B, Series A (2015), Series C (2018), Series D (2019)

Venture Capital

China

8/29/2017

11/2/2019

3
Series B, Series C (2018), Series D (2019)

Venture Capital

China

10/30/2018

11/2/2019

2
Series C, Series D (2019)

Asset/Investment Management

China

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Asset/Investment Management

China

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

China

First funding

11/24/2015

8/29/2017

10/30/2018

00/00/0000

00/00/0000

Last Funding

11/2/2019

11/2/2019

11/2/2019

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

4
Series B, Series A (2015), Series C (2018), Series D (2019)
3
Series B, Series C (2018), Series D (2019)
2
Series C, Series D (2019)

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Venture Capital

Venture Capital

Asset/Investment Management

Asset/Investment Management

Venture Capital

Location

China

China

China

China

China

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.